Cargando…
The parable of the Therapeutic Goods Administration approval of esketamine (Spravato) in Australia
OBJECTIVE: To review the sequence of events that led to the Therapeutic Goods Administration (TGA) approval of esketamine in Australia, and to explore the potential ethical and clinical consequences of it. CONCLUSIONS: Trust in the TGA is of paramount importance to Australian psychiatrists. The appr...
Autor principal: | Lugg, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088336/ https://www.ncbi.nlm.nih.gov/pubmed/36802863 http://dx.doi.org/10.1177/10398562231156475 |
Ejemplares similares
-
The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists
por: Berger, Joshua J, et al.
Publicado: (2023) -
Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series
por: Ning, Anna Y, et al.
Publicado: (2023) -
Enduring neurological sequelae of benzodiazepine use: an Internet survey
por: Huff, Christy, et al.
Publicado: (2023) -
Outcomes of hyperbolic tapering of antidepressants
por: van Os, Jim, et al.
Publicado: (2023) -
Patients’ attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators
por: Eveleigh, Rhona, et al.
Publicado: (2019)